We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ASMB market cap is 73.36M. The company's latest EPS is USD -16.9790 and P/E is -0.79.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -23.4M | -24.74M | -19.56M | -17.49M | -15.05M |
Net Income | -23.15M | -22.4M | -18.95M | -16.9M | -14.42M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 14.8M | 15.96M | 79.11M | 6.25M | 0 |
Operating Income | -92.74M | -102.71M | -64.08M | -132.69M | -94.11M |
Net Income | -90.75M | -97.63M | -62.15M | -129.86M | -93.09M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 121.52M | 101.79M | 83.12M | 66.58M | 51.63M |
Total Liabilities | 19.11M | 19.13M | 12.78M | 11.63M | 9.92M |
Total Equity | 102.4M | 82.66M | 70.33M | 54.95M | 41.71M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 268.05M | 339.91M | 283.25M | 191.06M | 101.79M |
Total Liabilities | 57.39M | 66.69M | 42.68M | 22.13M | 19.13M |
Total Equity | 210.65M | 273.22M | 240.58M | 168.93M | 82.66M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -65.21M | -84.46M | -23.43M | -37.06M | -50.9M |
Investing | 74.08M | 90.64M | 10M | 1.64M | 20.52M |
Financing | 177k | 614k | 4.49M | 4.63M | 4.63M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -64.96M | -84.07M | -62.96M | -93.4M | -84.46M |
Investing | -135.4M | -50.32M | 68.07M | 26.52M | 90.64M |
Financing | 159.79M | 139.65M | 7.6M | 53.06M | 614k |
Market Cap | 73.36M |
Price to Earnings Ratio | -0.79 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.4 |
Price to Book Ratio | 0.89 |
Dividend Yield | - |
Shares Outstanding | 5.48M |
Average Volume (1 week) | 24k |
Average Volume (1 Month) | 18.13k |
52 Week Change | 19.89% |
52 Week High | 20.04 |
52 Week Low | 7.692 |
Spread (Intraday) | 0.2 (1.52%) |
Company Name | Assembly Biosciences Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.assemblybio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions